Risk of coronary heart disease in patients with HIV infection
- 30 November 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cardiology
- Vol. 11 (12), 728-741
- https://doi.org/10.1038/nrcardio.2014.167
Abstract
The lives of individuals infected with HIV who have access to combination antiretroviral therapy (cART) are substantially prolonged, which increases the risk of developing non-AIDS comorbidities, including coronary heart disease (CHD). In Europe and the USA, individuals with HIV infection have a similar to 1.5-fold increased risk of myocardial infarction relative to uninfected individuals. In Africa, the relative risk of myocardial infarction is unknown, but broadened access to life-extending cART suggests that rates of CHD will rise in this and other resource-constrained regions. Atherogenesis in HIV is affected by complex interactions between traditional and immune risk factors. cART has varied, regimen-specific effects on metabolic risk factors. Overall, cART seems to lessen proatherogenic immune activation, but does not eliminate it even in patients in whom viraemia is suppressed. Current strategies to decrease the risk of CHD in individuals infected with HIV include early initiation of cART regimens with the fewest metabolic adverse effects, and careful management of traditional CHD risk factors throughout treatment. Future strategies to prevent CHD in patients with HIV infection might involve the use of HIV-tailored CHD risk-prediction paradigms and the administration of therapies alongside cART that will further decrease proatherogenic HIV-specific immune activation.Keywords
This publication has 201 references indexed in Scilit:
- Management of Human Immunodeficiency Virus Infection in Advanced AgeJama-Journal Of The American Medical Association, 2013
- Sudden Cardiac Death in Patients With Human Immunodeficiency Virus InfectionJournal of the American College of Cardiology, 2012
- Management of the metabolic effects of HIV and HIV drugsNature Reviews Endocrinology, 2011
- Mutation of the ATP Cassette Binding Transporter A1 (ABCA1) C-Terminus Disrupts HIV-1 Nef Binding but Does Not Block the Nef Enhancement of ABCA1 Protein DegradationBiochemistry, 2010
- Lipoprotein particle subclasses, cardiovascular disease and HIV infectionAtherosclerosis, 2009
- HIV Nef Protein Causes Endothelial Dysfunction in Porcine Pulmonary Arteries and Human Pulmonary Artery Endothelial CellsJournal of Surgical Research, 2009
- Highly active antiretroviral therapy drugs inhibit in vitro cholesterol efflux from human macrophage-derived foam cellsLaboratory Investigation, 2009
- Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1Nature Medicine, 2009
- Endothelial Function in Human Immunodeficiency Virus-Infected Antiretroviral-Naive Subjects Before and After Starting Potent Antiretroviral Therapy: The ACTG (AIDS Clinical Trials Group) Study 5152sJournal of the American College of Cardiology, 2008
- Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaborationThe Lancet, 2008